As part of the continuing global launch of its Spot® Ex Endoscopic tattoo, GI Supply Inc. announced that it is now available in two additional markets: Australia & New Zealand.
Spot® Ex is used to endoscopically mark cancerous tissue, suspicious lesions and polyps for easier future identification at a future colonoscopy or surgery. It is the only endoscopic tattoo to have a long-term clinical surveillance indication that empowers gastroenterologists to implement new guidelines.
Australia & New Zealand represent a combined total of 20,000 cases of colorectal cancer every year, and it is the second most common cancer in the region. Through its local distributors, GI Supply is excited to be able to offer gastroenterologists in both countries the opportunity to use Spot Ex on their patients:
Endomed Pty. Ltd.
“Endomed is excited to announce that SPOT EX is now available in Australia. This advancement will support clinicians by allowing longer term follow up as well as providing better care for patients.”
– Deborah Jew
Obex Medical Ltd.
“Obex Medical are delighted to launch Spot Ex into the New Zealand market. The expanded indications and new features of Spot Ex will assist clinicians in being able to provide the best diagnosis and therapy to ensure the best outcomes for our patients.”
– Jackie Shaw
Learn more about Spot Ex in these countries at www.spotextattoo.eu
Orders can be placed by phone at (800) 451-5797 or by Email at email@example.com
Contact: Dan McCoy, Vice President, Marketing